|
End-of-day quote
Nasdaq
2026-09-17
|
5-day change | 1st Jan Change | ||
| 1.910 USD | 0.00% |
|
+6.11% | -78.85% |
| 09-14 | EnGene Therapeutics Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 07:00 AM | |
| 09-08 | EnGene Therapeutics Inc. Provides Clinical Updates | CI |
Stock exchange
Quotes 5-day view: enGene Therapeutics Inc.
End-of-day quote Nasdaq| 2026-09-14 | 2026-09-15 | 2026-09-16 | 2026-09-17 | 2026-09-18 | |
|---|---|---|---|---|---|
| Last | US$1.870 | US$1.890 | US$1.910 | US$1.910 | US$1.910 |
| Volume | 460,523 | 618,745 | 579,256 | 637,548 | 400,979 |
| Change | +3.89% | +1.07% | +1.06% | 0.00% | 0.00% |
| Opening | US$1.800 | US$1.870 | US$1.900 | US$1.900 | US$1.920 |
| High | US$1.880 | US$1.900 | US$1.915 | US$1.920 | US$1.930 |
| Low | US$1.800 | US$1.845 | US$1.880 | US$1.880 | US$1.890 |
Performance
| 1 week | +6.11% | ||
| Current month | +3.80% | ||
| 1 month | +11.05% | ||
| 3 months | +11.05% | ||
| 6 months | -73.40% | ||
| Current year | -78.85% | ||
| 1 year | -72.56% | ||
| 3 years | -82.53% |
Volumes
marketsDaily volume
637,548
Avg. Volume 20 sessions
617,604
Avg. Volume 20 sessions USD
1,179,623.64
Record volume 1
51,454,331
Record volume 2
24,102,681
Record volume 3
17,386,929
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
128,001,163
Net sales (USD)
0
Free-Float
99.9%
Free-Float capitalization (USD)
127,869,230
Average Daily Capital Traded
0.92%
Indicators
Moving average 5 days
1.88
Moving average 20 days
1.85
Moving average 50 days
1.83
Moving average 100 days
2.23
Price spread / (MMA5)
-1.57%
Price spread / (MMA20)
-3.14%
Price spread / (MMA50)
-4.19%
Price spread / (MMA100)
+16.75%
STIM
RSI 9 days
58.5
RSI 14 days
55.55
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +6.11% | -72.56% | -82.53% | 128M | |
| -0.31% | +5.79% | +48.93% | +97.53% | 70.88B | |
| +0.39% | +2.06% | +40.91% | +78.49% | 62.49B | |
| -3.21% | -7.27% | -17.73% | +351.98% | 26.21B | |
| +0.50% | +7.13% | +29.43% | +15.48% | 26.34B | |
| -2.64% | -0.69% | -0.26% | -11.90% | 24.13B | |
| +0.71% | +8.03% | +27.22% | -13.18% | 20.72B | |
| -1.26% | -7.81% | +169.33% | +302.38% | 15.36B | |
| -0.22% | +3.99% | +44.28% | +173.35% | 14.46B | |
| +0.73% | +1.71% | -7.18% | +886.19% | 14.25B | |
| Average | -0.53% | +2.10% | +26.24% | +179.78% | 27.5B | |
| Weighted average by Cap. | -0.47% | +1.44% | +36.46% | +147.87% |
Historical Quotes: enGene Therapeutics Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 1.8 |  | 1.93 |
| 1 month | 1.75 | | 1.95 |
| Current year | 1.4 | | 12.25 |
| 1 year | 1.4 | | 12.25 |
| 3 years | 1.4 | | 47.17 |
| 5 years | 1.4 | | 47.17 |
| 10 years | 1.4 | | 47.17 |
Monthly variations
Annual variations
| 2026 | -78.85% | ||
| 2025 | +35.79% | ||
| 2024 | -27.95% | ||
| 2023 | -10.65% | ||
| 2022 | +4.77% |
- Stock Market
- Stocks
- ENGN Stock
- Quotes enGene Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
